Centre Jean-Perrin (UNICANCER)
Hospital
Location:
Clermont-Ferrand,
France (FR)
ISNI: 0000000417951689
ROR: https://ror.org/02pwnhd33
Show on Map:
Europe-side external quality assessment (EQA) of RNA based testing of ER, PR, HER2 and Ki67 in invasive breast cancer (2020)
Erber R, Hartmann A, Fasching P, Stöhr R, Beckmann M, Zentgraf M, Rübner M, et al.
Conference contribution
Bevacizumab and platinum-based combinations for recurrent ovarian cancer: a randomised, open-label, phase 3 trial (2020)
Pfisterer J, Shannon CM, Baumann K, Rau J, Harter P, Joly F, Sehouli J, et al.
Journal article, Original article
Salvage Mastectomy Versus Second Conservative Treatment for Second Ipsilateral Breast Tumor Event: A Propensity-Score Matched Cohort Analysis (2018)
Levi JMH, Van Limbergen E, Gal J, Schiappa R, Polgar C, Kauer-Dorner D, Pasquier D, et al.
Conference contribution
Hepatic intra-arterial versus intravenous fotemustine in patients with liver metastases from uveal melanoma (EORTC 18021): a multicentric randomized trial (2014)
Leyvraz S, Piperno-Neumann S, Suciu S, Baurain JF, Zdzienicki M, Testori A, Marshall E, et al.
Journal article